Read the latest positive news, breakthroughs, and inspiring stories about mount sinai, curated daily by BrightWire.
Scientists just launched miniature hearts and brains to the International Space Station to study how space accelerates aging. The groundbreaking research could lead to new treatments for Alzheimer's, Parkinson's, and age-related diseases back on Earth.
Mount Sinai researchers discovered how to reverse brain damage caused by APOE4, the strongest genetic risk factor for Alzheimer's disease. The breakthrough reveals new treatment targets that could protect millions at high risk for dementia.
Scientists discovered ultra-rare neurons in the brain's thinking center that actively help you fall asleep, challenging 100 years of sleep science. The finding could unlock new ways to treat sleep disorders affecting millions.
Researchers discovered a protein that acts like a brake on nerve repair, and blocking it helped paralyzed mice regain movement. The breakthrough could one day lead to treatments for spinal cord injuries and nerve damage in humans.
Researchers at Mount Sinai discovered a hidden pocket in a cancer protein that could lead to safer, more precise cancer drugs. The breakthrough reveals both AI's power and its limits in drug discovery.
Mount Sinai researchers discovered that focused radiation helps CAR-T therapy work better against tough-to-treat solid tumors like lung cancer and melanoma. The breakthrough could make this life-saving treatment safer and more effective for thousands of cancer patients.
Cancer patients considering clinical trials at Mount Sinai can now connect one-on-one with trained mentors who've walked the same path. The new PATHS program pairs patients with survivors and caregivers who understand their fears and questions firsthand.
Mount Sinai researchers made old blood stem cells behave like young ones again by repairing tiny cellular recycling centers, boosting their regenerative power eightfold. This discovery could lead to treatments that help elderly people maintain healthier immune systems and reduce risks of blood disorders.
Cancer patients at Mount Sinai can now connect one-on-one with trained mentors who've walked the same path, making treatment decisions feel less isolating. The new PATHS program especially helps patients understand clinical trials through personal experience, not just medical jargon.
Mount Sinai researchers have discovered a breakthrough immunotherapy combination that achieved complete tumor elimination in colorectal cancer models. The treatment restores communication between immune cells, offering hope for patients who don't respond to current therapies.
Doctors in New York just became the first in the world to use a newly approved liver cancer treatment that lets them schedule patients on more days of the week. The breakthrough could mean shorter wait times and better access for cancer patients when every day counts.
Scientists discovered why some bladder cancer patients don't respond to immunotherapy by linking common blood markers to immune suppression inside tumors. The breakthrough could help doctors identify resistant cases earlier and develop better combination treatments.